251 related articles for article (PubMed ID: 33826022)
21. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya.
Pintye J; Odoyo J; Nyerere B; Achieng P; Araka E; Omondi C; Ortblad KF; Mugambi ML; Baeten JM; Bukusi EA
AIDS; 2023 Mar; 37(4):617-623. PubMed ID: 36653342
[TBL] [Abstract][Full Text] [Related]
22. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.
Roberts DA; Barnabas RV; Abuna F; Lagat H; Kinuthia J; Pintye J; Bochner AF; Forsythe S; Gomez GB; Baeten JM; John-Stewart G; Levin C
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25296. PubMed ID: 31328443
[TBL] [Abstract][Full Text] [Related]
23. Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers.
Thuo N; Polay M; Leddy AM; Ngure K; Chatterhee P; Gandhi M; Amico KR
AIDS Behav; 2021 Nov; 25(11):3617-3629. PubMed ID: 33893877
[TBL] [Abstract][Full Text] [Related]
24. Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya.
Mugwanya KK; Irungu E; Bukusi E; Mugo NR; Odoyo J; Wamoni E; Ngure K; Morton JF; Peebles K; Masyuko S; Barnabee G; Donnell D; Barnabas R; Haberer J; O'Malley G; Baeten JM;
Implement Sci; 2018 Sep; 13(1):118. PubMed ID: 30180860
[TBL] [Abstract][Full Text] [Related]
25. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
26. Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
Crawford ND; Harrington KRV; Alohan DI; Sullivan PS; Holland DP; Klepser DG; Quamina A; Siegler AJ; Young HN
JMIR Res Protoc; 2022 Feb; 11(2):e35590. PubMed ID: 35138252
[TBL] [Abstract][Full Text] [Related]
27. Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.
Harrison C; Family H; Kesten J; Denford S; Scott A; Dawson S; Scott J; Sabin C; Copping J; Harryman L; Cochrane S; Horwood J
J Int AIDS Soc; 2024 Mar; 27(3):e26232. PubMed ID: 38494652
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya.
Ngure K; Heffron R; Mugo N; Thomson KA; Irungu E; Njuguna N; Mwaniki L; Celum C; Baeten JM
J Int AIDS Soc; 2017 Feb; 20(1):21234. PubMed ID: 28362073
[TBL] [Abstract][Full Text] [Related]
29. Attitudes about community pharmacy access to HIV prevention medications in California.
Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
[TBL] [Abstract][Full Text] [Related]
30. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
31. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.
Crawford ND; Josma D; Morris J; Hopkins R; Young HN
J Am Pharm Assoc (2003); 2020; 60(4):602-608. PubMed ID: 32007364
[TBL] [Abstract][Full Text] [Related]
32. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
[TBL] [Abstract][Full Text] [Related]
33. Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya.
Odoyo JB; Morton JF; Ngure K; O'Malley G; Mugwanya KK; Irungu E; Awuor M; Dolla A; Ongolly F; Bukusi EA; Mugo NR; Baeten JM;
J Int AIDS Soc; 2019 Jul; 22 Suppl 3(Suppl Suppl 3):e25303. PubMed ID: 31321911
[TBL] [Abstract][Full Text] [Related]
34. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda.
Ayieko J; Petersen ML; Kabami J; Mwangwa F; Opel F; Nyabuti M; Charlebois ED; Peng J; Koss CA; Balzer LB; Chamie G; Bukusi EA; Kamya MR; Havlir DV
J Int AIDS Soc; 2021 Jun; 24(6):e25670. PubMed ID: 34152067
[TBL] [Abstract][Full Text] [Related]
35. Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.
Zhao A; Dangerfield DT; Nunn A; Patel R; Farley JE; Ugoji CC; Dean LT
AIDS Behav; 2022 May; 26(5):1377-1392. PubMed ID: 34669062
[TBL] [Abstract][Full Text] [Related]
36. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
[TBL] [Abstract][Full Text] [Related]
37. Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study.
Ogello VA; Rono BK; Ngure K; Sedah E; Thuo NB; Musinguzi N; Baeten JM; Bukusi EA; Mugo NR; Haberer JE
PLoS One; 2024; 19(3):e0299168. PubMed ID: 38451884
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
[TBL] [Abstract][Full Text] [Related]
39. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
[TBL] [Abstract][Full Text] [Related]
40. Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya.
Pintye J; Rogers Z; Kinuthia J; Mugwanya KK; Abuna F; Lagat H; Sila J; Kemunto V; Baeten JM; John-Stewart G; Unger JA
Glob Health Sci Pract; 2020 Mar; 8(1):55-67. PubMed ID: 32139420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
